167 related articles for article (PubMed ID: 8191267)
1. [Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis].
Mentha G; Giostra E; Perrin L; Widmann JJ; Stelling MJ; Easton J; Morel P; Huber O; Le Coultre C; Bühler L
Schweiz Med Wochenschr; 1994 Apr; 124(15):637-41. PubMed ID: 8191267
[TBL] [Abstract][Full Text] [Related]
2. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
3. [Recurrence of virus B hepatitis after liver transplantation].
Gugenheim J; Crafa F; Fabiani P; Militerno G; Goubaux B; Saint-Paul MC; Ouzan D; Mouiel J
Gastroenterol Clin Biol; 1992; 16(5):430-3. PubMed ID: 1326456
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
[TBL] [Abstract][Full Text] [Related]
5. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
7. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.
Samuel D; Feray C; Bismuth H
Clin Transpl; 1994; ():157-62. PubMed ID: 7547534
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in European patients with the hepatitis B surface antigen.
Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
[TBL] [Abstract][Full Text] [Related]
11. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.
Segovia R; Sánchez-Fueyo A; Rimola A; Grande L; Bruguera M; Costa J; Soguero C; Uriz J
Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.
Adler R; Safadi R; Caraco Y; Rowe M; Etzioni A; Ashur Y; Shouval D
Hepatology; 1999 Apr; 29(4):1299-305. PubMed ID: 10094978
[TBL] [Abstract][Full Text] [Related]
13. Long-term prevention of recurrent hepatitis B virus after liver transplantation.
Ilan Y; Eid A; Tur-Kaspa R
Isr J Med Sci; 1995 Aug; 31(8):469-73. PubMed ID: 7635695
[TBL] [Abstract][Full Text] [Related]
14. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
15. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
16. Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.
Roche B; Samuel D; Feray C; Majno P; Gigou M; Reynes M; Bismuth H
Liver Transpl Surg; 1999 May; 5(3):166-74. PubMed ID: 10226106
[TBL] [Abstract][Full Text] [Related]
17. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
Radecke K; Frühauf NR; Miller M; Ross B; Köditz R; Malagó M; Broelsch CE; Gerken G; Treichel U
Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406
[TBL] [Abstract][Full Text] [Related]
18. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the changes of HBV serum markers and HBV DNA and the effects of perioperative factors after liver transplantation].
Tang YM; Chen GH; He XS; Zhu XF; Chen MH
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):164-7. PubMed ID: 15760545
[TBL] [Abstract][Full Text] [Related]
20. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.
Arslan M; Wiesner RH; Sievers C; Egan K; Zein NN
Liver Transpl; 2001 Apr; 7(4):314-20. PubMed ID: 11303291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
